Graham Anthony, CFO of Biovista, Inc., presents at the OneMedForum New York 2010.
News
BioWorld: Obesity Report : Tipping the Market Scales with Biotech & Med-Tech Regimens
BioWorld & Medical Device Daily BioVista Inc. has drugs in various stages of research and preclinical development for eye disorders, diabetes and obesity. According to its website, the Charlottesville, Va.-based company has identified four novel targets involved in diabetes and obesity that lend them- selves to the development of RNAi drugs. Using artificial intelligence (AI), … Read More
Biovista sponsors Drug Redevelopment and Product Pipeline Enhancement Conference
Charlottesville, VA (22 February 2010): Biovista Inc. announced today that it is sponsoring the 2010 Drug Redevelopment and Product Pipeline Enhancement Conference taking place in London, February 25 and 26, 2010. This open business platform which will be held at the London Marriott Regents Park hotel, offers pharmaceutical and biotech entities the opportunity to showcase their latest … Read More
Biovista Inc. and FDA to Collaborate on a Medication Safety Initiative
CHARLOTTESVILLE, Virginia, January 12 /PRNewswire/ — Biovista Inc. today announced that the U.S. Food and Drug Administration (FDA) has licensed its technology platform to help analyze, identify, and better understand the way certain drugs can cause harmful side effects. The FDA’s Office of Clinical Pharmacology, within the Center for Drug Evaluation and Research (CDER), will … Read More
Biovista to present at the 2nd International Conference on Drug Discovery and Therapy
Charlottesville, VA (11 January 2010) Biovista Inc. announced today that it will be present at the 2nd International Conference on Drug Discovery and Therapy (ICDDT 2010) held in Dubai, UAE, Jan 31 – February 4th, 2010. Biovista’s CEO, Dr. Andreas Persidis will give an invited lecture highlighting the efficiencies of repositioning as a development strategy, … Read More